Cure Pharmaceutical Holding Co - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
CURR Over the counter 3841 https://curepharmaceutical.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Cure Pharmaceutical Holding Co

Sera Labs, a Subsidiary of CURE Pharmaceutical, Consummates Exclusive International Distribution Agreement With Leading Canadian Distributor - Dec 9th, 2021 12:30 pm
CURE Pharmaceutical Receives Patent Approval for Its CUREfilm Blue™ Technology - Nov 16th, 2021 12:30 pm
CURE Pharmaceutical Reports Second Quarter 2021 Revenue Rose Nearly 700% Driven by Sales from Sera Labs Product Lines - Aug 17th, 2021 12:00 pm
Keynotes, Educational Panels and 60 Companies to Present at the SNN Network Summer Virtual Event on August 17-19, 2021 - Aug 16th, 2021 12:30 pm
Seratopical Revolution Skincare Line by The Sera Labs Inc., a CURE Pharmaceutical Company, will be Available for Purchase this Fall at CVS, one of the Leading National Drug Store Chains - Aug 4th, 2021 11:00 am
CURE Pharmaceutical to Present at H.C. Wainwright 2021 Psychedelics in Psychiatry and Beyond Virtual Conference - Jun 15th, 2021 12:15 pm
CURE Pharmaceutical Signs Agreement to Develop CBD and THC Oral Thin Films and Conduct Clinical Studies Targeting Veteran Health - Jun 10th, 2021 12:15 pm
Nicole Kidman and Sera Labs Inc., a CURE Pharmaceutical Company, Launch Seratopical Revolution and New Ad Campaign - Jun 9th, 2021 12:15 pm
CURE Pharmaceutical Schedules Investor Webcast for Thursday, May 27, 2021 - May 25th, 2021 1:00 pm
CURE Pharmaceutical First Quarter Revenue Quadruples to $1.5 million; Company Expands Clinical Pipeline to Include Psychedelics - May 17th, 2021 1:15 pm
CURE Pharmaceutical Receives ISO Certification for Laboratory and Manufacturing Facility - May 13th, 2021 12:15 pm
Nicole Kidman, Sera Labs Strategic Business Partner/Global Brand Ambassador and Nancy Duitch, Sera Labs Founder/CEO Headline Collision 2021 and Talk the Future of Beauty Technology - Apr 28th, 2021 12:15 pm
CURE Pharmaceutical Announces Successful Results From Initial Clinical Trials for Erectile Dysfunction Product CUREfilm Blue™ - Apr 21st, 2021 12:15 pm
CURE Pharmaceutical to Present at the 2021 Sequire Cannabis Conference on Tuesday, April 20, at 2 p.m. EDT/11 a.m. PDT - Apr 19th, 2021 12:30 pm
Nicole Kidman, Sera Labs Strategic Business Partner/Global Brand Ambassador and Nancy Duitch, Sera Labs Founder/CEO Headline Collision 2021 - Apr 13th, 2021 12:15 pm
CURE Pharmaceutical Reports Increase in Revenue to $7.7 Million on a Pro Forma Basis in 2020 - Apr 1st, 2021 12:30 pm
CURE Pharmaceutical Augments Its Existing U.S. DEA License in Order to Initiate Development of Its Psychedelics-Based Pharmaceutical Clinical Pipeline - Mar 23rd, 2021 12:30 pm
CURE Pharmaceutical Launches Psychedelic Oral Film Program Targeting the Treatment of Mental Health Disorders - Mar 16th, 2021 12:45 pm
CURE Pharmaceutical Announces Addition of Two New Clinical Development Programs Targeting Anti-Seizure and Antiviral Applications - Mar 10th, 2021 1:15 pm
CURE Pharmaceutical’s Subsidiary Sera Labs Launches National Television, Radio & Digital Advertising Campaign for Nutri-Strips Sleep A.S.A.P. - Mar 3rd, 2021 1:15 pm